Nkarta (NKTX) Interest Expenses (2019 - 2026)
Nkarta's (NKTX) quarterly Interest Expenses came in at $6.0 million in Q1 2026, up 8.09% year-on-year from $5.6 million in Q1 2025, and down 1.43% quarter-over-quarter from $6.1 million in Q4 2025.
Nkarta (NKTX) Interest Expenses (2019 - 2026) Analysis & Trends
Nkarta's Interest Expenses history runs 8 years deep, the most recent figure standing at $6.0 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 8.09% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $22.4 million, a 30.62% decrease from a year earlier, with the FY2025 full-year figure at $151.4 million, up 643.87% from the prior year.
- Interest Expenses retreated to $6.0 million in Q1 2026 per NKTX's latest filing, from $6.1 million in the prior quarter.
- Across five years, Interest Expenses topped out at $146.9 million in Q2 2023 and bottomed at $600000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $6.2 million (2024), against an average of $37.5 million.
- Across the five-year window, Interest Expenses surged 5343.27% in 2022 and tumbled 96.08% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $4.0 million in 2022, then jumped by 294.88% to $15.7 million in 2023, then sank by 69.69% to $4.8 million in 2024, then advanced by 27.54% to $6.1 million in 2025, then retreated by 1.43% to $6.0 million in 2026.
- Per Business Quant, the three latest NKTX Interest Expenses figures stand at $6.0 million (Q1 2026), $6.1 million (Q4 2025), and $37.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.09 Mn |
| Dec 31, 2025 | 6.09 Mn |
| Sep 30, 2025 | 37.08 Mn |
| Sep 30, 2025 | 37.08 Mn |
| Jun 30, 2025 | 38.93 Mn |
| Jun 30, 2025 | 38.93 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Mar 31, 2025 | 5.55 Mn |
| Dec 31, 2024 | 4.77 Mn |
| Dec 31, 2024 | 4.77 Mn |
| Sep 30, 2024 | 6.23 Mn |
| Sep 30, 2024 | 6.23 Mn |
| Jun 30, 2024 | 5.76 Mn |
| Jun 30, 2024 | 5.76 Mn |
| Mar 31, 2024 | 30.91 Mn |
| Mar 31, 2024 | 30.91 Mn |
| Dec 31, 2023 | 15.74 Mn |
| Dec 31, 2023 | 15.74 Mn |